Antibacterial effect of green tea against Porphyromonas gingivalis: a literature review
Main Article Content
Abstract
Green tea is regarded as a healthy beverage due to the biological action of polyphenols, specifically catechins. Researchers investigated the inhibitory effects of green tea (Camellia sinensis) plant on both Gram- positive and Gram-negative bacteria. Periodontitis is mainly initiated when dysbiosis of the subgingival microbiome takes place. Porphyromonas gingivalis is one of the key pathogens involved in the initiation and progression of periodontitis when its levels in subgingival biofilm overwhelm the host's immune system. It is the main pathogen that is significantly linked to severe periodontal disease. In this study, details about P. gingivalis including information about its structure, virulence factors were provided. Next, Important points related to green tea, including its active ingredients and antibacterial activity, have been clarified. Finally, the objective of this study was to demonstrate how green tea has antibacterial effects on P. gingivalis.
Received date: 01-04-2022
Accepted date: 29-08-2022
Published date: 15-03-2024
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
References
Fiorillo L, Cervino G, Laino L, D’Amico C, Mauceri R, Tozum TF, et al. Porphyromonas gingivalis, periodontal and systemic implications: a systematic review. Dent J 2019;7(4):114.
Mysak J, Podzimek S, Sommerova P, Lyuya-Mi Y, Bartova J, Janatova T, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J immun res 2014;2014.
Liu X, Sroka A, Potempa J, Genco CA. Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuR. Bio chem 2004;385(11):1049-57.
Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell–cell distance. nat. Rev Micro 2010;8(7):471-80.
Singh A, Wyant T, Anaya-Bergman C, Aduse-Opoku J, Brunner J, Laine ML, et al. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect immun 2011;79(11):4533-42.
Oliver WW, Wherry WB. Notes on some bacterial parasites of the human mucous membranes. J Infec Dis 1921:341-4.
Koebnik R, Locher KP, Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Molec micro 2000;37(2):239-53.
Capestany CA, Tribble GD, Maeda K, Demuth DR, Lamont RJ. Role of the Clp system in stress tolerance, biofilm formation, and intracellular invasion in Porphyromonas gingivalis. J bacterio 2008;190(4):1436-46.
Smalley JW, Byrne DP, Birss AJ, Wojtowicz H, Sroka A, Potempa J, et al. HmuY haemophore and gingipain proteases constitute a unique syntrophic system of haem acquisition by Porphyromonas gingivalis. PLoS One 2011;6(2):e17182.
Carranza F, Newman M. Takei HH Klokkevold PR Carranza's Clinical Periodontology. St. Louis, Mo.: Elsevier Saunders; 2012.
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Re. Immunol 2015;15(1):30-44.
Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 2011;11(3):187-200.
Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol 2020;120:45-84.
Olsen I, Lambris JD, Hajishengallis G. Porphyromonas gingivalis disturbs host–commensal homeostasis by changing complement function. J oral micro 2017;9(1):1340085.
Tanner AC, Kent JR, Kanasi E, Lu SC, Paster BJ, Sonis ST, et al. Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults. J clin periodontol 2007;34(11):917-30.
Hojo K, Tamura A, Mizoguchi C, Kato D, Ohshima T, Maeda N. Predominant bacteria recovered from a periodontitis site in a hamster model raised by silk-ligature with Prophyromonas gingivalis infection. Biosci Biotechnol Biochem 2008;72(5):1348-51.
Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immuno 2001;1(2):135-45.
Darveau RP, Arbabi S, Garcia I, Bainbridge B, Maier RV. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect immun 2002;70(4):1867-73.
Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu rev biochem 2002;71:635.
Herath TD, Wang Y, Seneviratne CJ, Darveau RP, Wang C-Y, Jin L. The expression and regulation of matrix metalloproteinase-3 is critically modulated by Porphyromonas gingivalis lipopolysaccharide with heterogeneous lipid A structures in human gingival fibroblasts. BMC microbiology. 2013;13(1):1-12.
Lee S, Baek D. Characteristics of P orphyromonas gingivalis lipopolysaccharide in co‐culture with Fusobacterium nucleatum. Mol oral microbiol 2013;28(3):230-8.
Amano A. Host–parasite interactions in periodontitis: microbial pathogenicity and innate immunity. Periodontol 2000. 2010;54(1):9-14.
Amano A. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J periodontol 2003;74(1):90-6.
Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS microbiol letters. 2012;333(1):1-9.
Mezyk-Kopec R, Bzowska M, Potempa J, Bzowska M, Jura N, Sroka A, et al. Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis. Infect immun 2005;73(3):1506-14.
Diego I, Veillard F, Sztukowska MN, Guevara T, Potempa B, Pomowski A, et al. Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis. J Bio Chem 2014;289(46):32291-302.
Kadowaki T, Baba A, Abe N, Takii R, Hashimoto M, Tsukuba T, et al. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol. Pharmacol 2004;66(6):1599-606.
Smalley JW, Birss AJ, Szmigielski B, Potempa J. Mechanism of methaemoglobin breakdown by the lysine-specific gingipain of the periodontal pathogen Porphyromonas gingivalis. 2008.
Lourbakos A, Yuan Y, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood, J Am Soc Hematol 2001;97(12):3790-7.
Imamura T, Travis J, Potempa J. The biphasic virulence activities of gingipains: activation and inactivation of host proteins. Current Protein and Peptide Science. 2003;4(6):443-50.
Karin Kristoffersen A, Solli SJ, Duy Nguyen T, Enersen M. Association of the rgpB gingipain genotype to the major fimbriae (fimA) genotype in clinical isolates of the periodontal pathogen Porphyromonas gingivalis. J oral microbiol 2015;7(1):29124.
Laine M, Appelmelk B, Van Winkelhoff A. Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients. J dent res 1997;76(12):1840-4.
Cole KL, Seymour G, Powell R. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J periodontol 1987;58(8):569-73.
Shenker BJ, Datar S. Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun 1995;63(12):4830-6.
Stashenko P, Resmini L, Haffajee A, Socransky S. T cell responses of periodontal disease patients and healthy subjects to oral microorganisms. J periodontol res. 1983;18(6):587-600.
Khalaf H, Bengtsson T. Altered T-cell responses by the periodontal pathogen Porphyromonas gingivalis. 2012.
Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999;67(6):2804-9.
Kuramitsu HK, Kang IC, Qi M. Interactions of Porphyromonas gingivalis with host cells: implications for cardiovascular diseases. J periodontol 2003;74(1):85-9.
Alonso S, Reveneau N, Pethe K, Locht C. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role. Infect Immun 2002;70(8):4142-7.
Han N, Whitlock J, Progulske-Fox A. The hemagglutinin gene A (hagA) of Porphyromonas gingivalis 381 contains four large, contiguous, direct repeats. Infect Immun 1996;64(10):4000-7.
Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, Nakayama K, et al. Effect of inactivation of the Arg-and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis. Infect Immun 2003;71(8):4742-8.
Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. 1999;20(1):168-238.
Grenier D, Mayrand D. Selected characteristics of pathogenic and nonpathogenic strains of Bacteroides gingivalis. J Clin Microbiol 1987;25(4):738-40.
Wheeler DS, Wheeler WJ. The medicinal chemistry of tea. Drug develop res 2004;61(2):45-65.
Zongmao C. Prospect on tea industry in the year of 2000. J Tea Sci (China). 1994.
Taylor PW, Hamilton-Miller JM, Stapleton PD. Antimicrobial properties of green tea catechins. Food sci tech bullet. 2005;2:71.
Gramza A, Korczak J, Amarowicz R. Tea polyphenols-their antioxidant properties and biological activity-a review. Polish J food nutr sci 2005;14(3):219.
Song JM, Seong BL. Tea catechins as a potential alternative anti-infectious agent. Expert Rev Anti Infect Ther 2007;5(3):497-506.
Bernal P, Zloh M, Taylor PW. Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (−)-epicatechin gallate. J Antimicrob Chemother 2009;63(6):1156-62.
Arakawa H, Maeda M, Okubo S, Shimamura T. Role of hydrogen peroxide in bactericidal action of catechin. Biol Pharm Bull 2004;27(3):277-81.
Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37(8):693-704.
Barreira S, Moutinho C, Silva AM, Neves J, Seo E-J, Hegazy M-EF, et al. Phytochemical characterization and biological activities of green tea (Camellia sinensis) produced in the Azores, Portugal. Phytomedicine Plus. 2021;1(1):100001.
Jiang H, Engelhardt UH, Thräne C, Maiwald B, Stark J. Determination of flavonol glycosides in green tea, oolong tea and black tea by UHPLC compared to HPLC. Food chem 2015;183:30-5.
Price KR, Rhodes MJ, Barnes KA. Flavonol glycoside content and composition of tea infusions made from commercially available teas and tea products. J Agric Food Chem 1998;46(7):2517-22.
Pitura K, Arntfield SD. Characteristics of flavonol glycosides in bean (Phaseolus vulgaris L.) seed coats. Food chem 2019;272:26-32.
Jigisha A, Nishant R, Navin K, Pankaj G. Green tea: a magical herb with miraculous outcomes. Int Res J Pharm. 2012;3(5):139-48.
Steinmann J, Buer J, Pietschmann T, Steinmann E. Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea. Br J Pharmacol 2013;168(5):1059-73.
Stapleton PD, Shah S, Hamilton-Miller JM, Hara Y, Nagaoka Y, Kumagai A, et al. Anti-Staphylococcus aureus activity and oxacillin resistance modulating capacity of 3-O-acyl-catechins. Int J Antimicrob Agents 2004;24(4):374-80.
Hara Y. Green tea: health benefits and applications: CRC press; 2001.
Abdulbaqi HR, Himratul-Aznita WH, Baharuddin NA. Anti-plaque effect of a synergistic combination of green tea and Salvadora persica L. against primary colonizers of dental plaque. Arch Oral Biol 2016;70:117-24.
Fournier-Larente J, Morin M-P, Grenier D. Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis. Arch Oral Biol 2016;65:35-43.
Araghizadeh A, Kohanteb J, Fani MM. Inhibitory activity of green tea (Camellia sinensis) extract on some clinically isolated cariogenic and periodontopathic bacteria. Med Princ Pract 2013;22(4):368-72.
Fajriani SS, Handayani H, Putri D. The role of green tea extract on inhibiting porphyromonas gingivalis as a major periodontitis pathogen: in vitro study. Sys Rev Pharm. 2020;11(8):152-5.
Pruthviraj P, Suchita B, Shital K, Shilpa K. Research Article Available online through. IJRAP. 2011;2(4):1354-7.
Okamoto M, Sugimoto A, Leung KP, Nakayama K, Kamaguchi A, Maeda N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol 2004;19(2):118-20.
Sakanaka S, Aizawa M, Kim M, Yamamoto T. Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem. 1996; 60 (5):
Sakanaka S, Okada Y. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J agricul food chem 2004;52(6):1688-92.